Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4292460
Max Phase: Preclinical
Molecular Formula: C46H52F3N7O11S
Molecular Weight: 968.02
Molecule Type: Small molecule
Associated Items:
ID: ALA4292460
Max Phase: Preclinical
Molecular Formula: C46H52F3N7O11S
Molecular Weight: 968.02
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@H]2C(CN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)=C(C(F)(F)F)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4
Standard InChI: InChI=1S/C46H52F3N7O11S/c1-27-3-7-36-34(40(46(47,48)49)64-43-45(36)35(27)9-13-44(2,65-43)66-67-45)26-54-15-17-55(18-16-54)30-4-6-33(39(22-30)63-31-21-29-10-14-50-41(29)52-25-31)42(57)53-68(60,61)32-5-8-37(38(23-32)56(58)59)51-24-28-11-19-62-20-12-28/h4-6,8,10,14,21-23,25,27-28,35-36,43,51H,3,7,9,11-13,15-20,24,26H2,1-2H3,(H,50,52)(H,53,57)/t27-,35+,36+,43-,44-,45-/m1/s1
Standard InChI Key: MFQHEQUEWDAVMV-VWDYGGEKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 968.02 | Molecular Weight (Monoisotopic): 967.3398 | AlogP: 7.40 | #Rotatable Bonds: 12 |
Polar Surface Area: 208.95 | Molecular Species: ACID | HBA: 15 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.18 | CX Basic pKa: 7.16 | CX LogP: 5.43 | CX LogD: 5.68 |
Aromatic Rings: 4 | Heavy Atoms: 68 | QED Weighted: 0.07 | Np Likeness Score: -0.14 |
1. Liu X, Zhang Y, Huang W, Luo J, Li Y, Tan W, Zhang A.. (2018) Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin., 159 [PMID:30278333] [10.1016/j.ejmech.2018.09.059] |
Source(1):